Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ETR
|
Leo P Denault
Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct | 27,036 Added 6.1% |
$1,707,864
$63.17 p/Share
|
Apr 05
2022 |
ES
|
James W Hunt Iii
EVP-Corp Rel & Sustainability |
SELL
Open market or private sale
|
Direct | 4,444 Reduced 21.62% |
$399,960
$90.0 p/Share
|
Apr 05
2022 |
SO
|
Greene Kimberly S,
Chairman, President & CEO, GPC |
SELL
Open market or private sale
|
Direct | 59,588 Reduced 32.61% |
$4,469,696
$75.01 p/Share
|
Apr 05
2022 |
SO
|
Greene Kimberly S,
Chairman, President & CEO, GPC |
BUY
Exercise of conversion of derivative security
|
Direct | 59,588 Added 26.53% |
-
|
Apr 05
2022 |
ADP
|
Deborah L Dyson
Corp. VP |
SELL
Open market or private sale
|
Direct | 2,787 Reduced 9.46% |
$653,691
$234.55 p/Share
|
Apr 05
2022 |
ADP
|
Deborah L Dyson
Corp. VP |
BUY
Exercise of conversion of derivative security
|
Direct | 2,787 Added 8.65% |
$194,310
$69.72 p/Share
|
Apr 05
2022 |
NOW
|
Frederic B Luddy
Director |
SELL
Open market or private sale
|
Indirect | 6,600 Reduced 0.19% |
$3,693,954
$559.69 p/Share
|
Apr 05
2022 |
WEN
|
May Peter W |
BUY
Grant, award, or other acquisition
|
Direct | 1,405 Added 0.03% |
$30,489
$21.7 p/Share
|
Apr 05
2022 |
WEN
|
Peltz Nelson |
BUY
Grant, award, or other acquisition
|
Direct | 1,042 Added 0.01% |
$22,611
$21.7 p/Share
|
Apr 05
2022 |
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.2% |
$1,532
$2.27 p/Share
|
Apr 05
2022 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.18% |
$4,253
$1417.73 p/Share
|
Apr 05
2022 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 15 Added 0.05% |
$21,266
$1417.73 p/Share
|
Apr 05
2022 |
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 113,756 Reduced 0.11% |
$33,489,766
$294.4 p/Share
|
Apr 05
2022 |
OSH
|
Geoffrey M Price
Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect | 60,000 Reduced 1.37% |
$1,615,200
$26.92 p/Share
|
Apr 05
2022 |
WMT
|
S Robson Walton
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 1,495,000 Reduced 0.52% |
-
|
Apr 05
2022 |
WMT
|
Alice L Walton
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 1,495,000 Reduced 0.52% |
-
|
Apr 05
2022 |
WMT
|
Jim C Walton
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 1,495,000 Reduced 0.52% |
-
|
Apr 05
2022 |
PLNT
|
William Bode
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 116 Reduced 1.55% |
$9,730
$83.88 p/Share
|
Apr 05
2022 |
GOOG
|
Philipp Schindler
SVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct | 3,907 Reduced 21.78% |
$11,098,029
$2840.55 p/Share
|
Apr 05
2022 |
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,300 Reduced 0.01% |
$491,924
$213.88 p/Share
|
Apr 05
2022 |
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,300 Added 0.01% |
$186,277
$80.99 p/Share
|
Apr 05
2022 |
PLSH
|
Leslie Buttorff
CEO |
BUY
Open market or private purchase
|
Direct | 1,050 Added 0.17% |
$504
$0.48 p/Share
|
Apr 05
2022 |
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$11,852
$4.31 p/Share
|
Apr 05
2022 |
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,750 Reduced 0.21% |
$11,852
$4.31 p/Share
|
Apr 05
2022 |
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,750 Reduced 0.21% |
$11,852
$4.31 p/Share
|
Apr 05
2022 |
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$11,852
$4.31 p/Share
|
Apr 05
2022 |
TBNK
|
Allan S Kitagawa
Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,074 Reduced 0.66% |
$25,540
$23.78 p/Share
|
Apr 05
2022 |
TBNK
|
Vernon Hirata
Vice Chairman & Co-COO |
SELL
Payment of exercise price or tax liability
|
Direct | 343 Reduced 0.39% |
$8,157
$23.78 p/Share
|
Apr 05
2022 |
TBNK
|
Ralph Y Nakatsuka
Vice Chairman & Co-COO |
SELL
Payment of exercise price or tax liability
|
Direct | 348 Reduced 0.21% |
$8,275
$23.78 p/Share
|
Apr 05
2022 |
FPH
|
Gary H Hunt
Director |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 35.89% |
$62,400
$6.24 p/Share
|
Apr 05
2022 |
GRPN
|
Jan Barta
Director |
BUY
Open market or private purchase
|
Indirect | 136,779 Added 2.91% |
$2,751,994
$20.12 p/Share
|
Apr 05
2022 |
NRC
|
Amandla Mk Trust |
SELL
Open market or private sale
|
Indirect | 5,627 Reduced 0.09% |
$227,275
$40.39 p/Share
|
Apr 05
2022 |
ISEE
|
Keith Westby
SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 9,298 Reduced 7.85% |
$176,848
$19.02 p/Share
|
Apr 05
2022 |
ISEE
|
Keith Westby
SVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,298 Added 7.28% |
$13,482
$1.45 p/Share
|
Apr 05
2022 |
KTOS
|
Steven S. Fendley
President, US Division |
SELL
Payment of exercise price or tax liability
|
Direct | 5,246 Reduced 1.56% |
$110,900
$21.14 p/Share
|
Apr 05
2022 |
KTOS
|
Steven S. Fendley
President, US Division |
BUY
Exercise of conversion of derivative security
|
Direct | 13,334 Added 3.8% |
-
|
Apr 05
2022 |
CRVL
|
V Gordon Clemons |
SELL
Open market or private sale
|
Indirect | 667 Reduced 0.14% |
$112,716
$168.99 p/Share
|
Apr 05
2022 |
HRMY
|
Jack Nielsen |
SELL
Open market or private sale
|
Indirect | 20,367 Reduced 7.61% |
$1,023,442
$50.25 p/Share
|
Apr 05
2022 |
GATX
|
Brian A Kenney
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 13,434 Reduced 13.27% |
$1,599,318
$119.05 p/Share
|
Apr 05
2022 |
CYTK
|
Ching Jaw
SVP Finance & CFO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 12.97% |
$420,000
$42.0 p/Share
|
Apr 05
2022 |
CYTK
|
Ching Jaw
SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 11.48% |
$121,000
$12.1 p/Share
|
Apr 05
2022 |
BRZE
|
Isabelle Winkles
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 93,000 Reduced 81.94% |
$3,631,650
$39.05 p/Share
|
Apr 05
2022 |
BRZE
|
Isabelle Winkles
Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct | 93,000 Added 45.04% |
-
|
Apr 05
2022 |
X
|
David B Burritt
Pres. & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 43,530 Added 5.06% |
$900,636
$20.69 p/Share
|
Apr 05
2022 |
X
|
David B Burritt
Pres. & CEO |
SELL
Open market or private sale
|
Direct | 43,530 Reduced 5.32% |
$1,654,140
$38.0 p/Share
|
Apr 05
2022 |
NET
|
Matthew Prince
CEO & Board Co-Chair |
SELL
Open market or private sale
|
Indirect | 52,384 Reduced 54.47% |
$6,428,041
$122.71 p/Share
|
Apr 05
2022 |
NET
|
Matthew Prince
CEO & Board Co-Chair |
BUY
Conversion of derivative security
|
Indirect | 52,384 Added 50.0% |
-
|
Apr 05
2022 |
VRTX
|
Yuchun Lee
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 51.61% |
$543,680
$271.84 p/Share
|
Apr 05
2022 |
VRTX
|
Yuchun Lee
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 34.04% |
$163,080
$81.54 p/Share
|
Apr 05
2022 |
VRTX
|
Bastiano Sanna
EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct | 3,163 Reduced 6.8% |
$870,553
$275.23 p/Share
|
Apr 05
2022 |